Literature DB >> 21518835

Characterization of metallo-beta-lactamase VIM-27, an A57S mutant of VIM-1 associated with Klebsiella pneumoniae ST147.

C C Papagiannitsis1, S D Kotsakis, E Petinaki, A C Vatopoulos, E Tzelepi, V Miriagou, L S Tzouvelekis.   

Abstract

VIM-27 metallo-β-lactamase, an Ala(57) → Ser variant of VIM-1, was identified in three Klebsiella pneumoniae isolates belonging to sequence type 147. bla(VIM-27) was part of a class 1 integron carried by non-self-transferable plasmids. Kinetic parameters and MIC determinations indicated that VIM-27 hydrolyzed most β-lactams, especially imipenem and cefoxitin, less effectively than VIM-1.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21518835      PMCID： PMC3122466          DOI： 10.1128/AAC.00238-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1.

Authors:  A Mavroidi; E Tzelepi; A Tsakris; V Miriagou; D Sofianou; L S Tzouvelekis
Journal:  J Antimicrob Chemother       Date:  2001-11       Impact factor: 5.790

2.  Novel variant (bla(VIM-4)) of the metallo-beta-lactamase gene bla(VIM-1) in a clinical strain of Pseudomonas aeruginosa.

Authors:  Spyros Pournaras; Athanassios Tsakris; Maria Maniati; Leonidas S Tzouvelekis; Antonios N Maniatis
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

3.  Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-beta-lactamase VIM-1.

Authors:  Vivi Miriagou; Eva Tzelepi; Dimitra Gianneli; Leonidas S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

4.  Genetic and enzymatic properties of metallo-beta-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae.

Authors:  Gulcin G Gacar; Kenan Midilli; Fetiye Kolayli; Kivanc Ergen; Sibel Gundes; Salih Hosoglu; Aynur Karadenizli; Haluk Vahaboglu
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

5.  Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.

Authors:  Frédéric Robin; Nadjet Aggoune-Khinache; Julien Delmas; Malek Naim; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

6.  Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate.

Authors:  L Lauretti; M L Riccio; A Mazzariol; G Cornaglia; G Amicosante; R Fontana; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

7.  Biochemical and structural characterization of the subclass B1 metallo-β-lactamase VIM-4.

Authors:  Patricia Lassaux; Daouda A K Traoré; Elodie Loisel; Adrien Favier; Jean-Denis Docquier; Jean Sébastien Sohier; Clémentine Laurent; Carine Bebrone; Jean-Marie Frère; Jean-Luc Ferrer; Moreno Galleni
Journal:  Antimicrob Agents Chemother       Date:  2010-12-13       Impact factor: 5.191

8.  Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.

Authors:  Stathis D Kotsakis; Vivi Miriagou; Eva Tzelepi; Leonidas S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

Review 9.  High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence.

Authors:  A Vatopoulos
Journal:  Euro Surveill       Date:  2008-01-24

10.  VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae.

Authors:  Jose-Manuel Rodriguez-Martinez; Patrice Nordmann; Nicolas Fortineau; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2009-11-16       Impact factor: 5.191
View more
  11 in total

1.  Detection and characterization of VIM-31, a new variant of VIM-2 with Tyr224His and His252Arg mutations, in a clinical isolate of Enterobacter cloacae.

Authors:  Pierre Bogaerts; Carine Bebrone; Te-Din Huang; Warda Bouchahrouf; Yves Degheldre; Ariane Deplano; Kurt Hoffmann; Youri Glupczynski
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

2.  Biochemical Characterization of VIM-39, a VIM-1-Like Metallo-β-Lactamase Variant from a Multidrug-Resistant Klebsiella pneumoniae Isolate from Greece.

Authors:  Costas C Papagiannitsis; Simona Pollini; Filomena De Luca; Gian Maria Rossolini; Jean-Denis Docquier; Jaroslav Hrabák
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

3.  Detection of a VIM-27-producing Klebsiella pneumoniae isolate in a patient following surgical tourism in Greece.

Authors:  P Bogaerts; R Rezende de Castro; A Deplano; W Bouchahrouf; C Tsobo; O Denis; Y Glupczynski
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

4.  Importance of Clonal Complex 258 and IncFK2-like Plasmids among a Global Collection of Klebsiella pneumoniae with blaKPC.

Authors:  Gisele Peirano; Patricia A Bradford; Krystyna M Kazmierczak; Liang Chen; Barry N Kreiswirth; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 5.  Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance.

Authors:  Johann D D Pitout; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

Review 6.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America.

Authors:  Christine Lascols; Gisele Peirano; Meredith Hackel; Kevin B Laupland; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

Review 8.  Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147.

Authors:  Gisele Peirano; Liang Chen; Barry N Kreiswirth; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

9.  Comparative population analysis of Klebsiella pneumoniae strains with extended-spectrum β-lactamases colonizing patients in rehabilitation centers in four countries.

Authors:  A Baraniak; R Izdebski; J Fiett; E Sadowy; A Adler; M Kazma; J Salomon; C Lawrence; A Rossini; A Salvia; J Vidal Samso; J Fierro; M Paul; Y Lerman; S Malhotra-Kumar; C Lammens; H Goossens; W Hryniewicz; C Brun-Buisson; Y Carmeli; M Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2013-02-12       Impact factor: 5.191

10.  Travel-related carbapenemase-producing Gram-negative bacteria in Alberta, Canada: the first 3 years.

Authors:  Gisele Peirano; Jasmine Ahmed-Bentley; Jeff Fuller; Joseph E Rubin; Johann D D Pitout
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.